Lipo-C
A compounded MIC+B12 blend studied and used in metabolic/wellness research contexts, not a single peptide molecule.
What Lipo-C is
Lipo-C is not one peptide. It is a compounded lipotropic blend that usually combines methionine, inositol, and choline (the classic MIC trio) with vitamin B12, and sometimes additional cofactors depending on the pharmacy formula. The ingredients are ordinary metabolic nutrients, not a receptor-targeted synthetic peptide like the other entries in this library.
Researchers and clinicians became interested in lipotropic combinations because choline and methionine participate in hepatic fat export and one-carbon metabolism, while B12 supports methylation and energy-related pathways. That biochemical rationale is real; high-quality randomized evidence that injectable MIC+B12 independently drives large fat-loss effects is much thinner than popular wellness marketing implies.
Educational pages should keep the distinction clear: Lipo-C is a multi-ingredient nutrient injection/research blend. Composition, strength, and volume vary by compounder, so “the dose” is formula-specific rather than a universal peptide mcg chart.
Lipo-C has been studied in human trials, which is not true of most compounds in this library. The figures below come from that work.
How it works
Choline is required for phosphatidylcholine synthesis and VLDL assembly that exports triglyceride from hepatocytes. Methionine contributes methyl groups through S-adenosylmethionine pathways tightly linked to choline metabolism. Inositol participates in phospholipid signaling and has been studied for metabolic effects especially in oral myo-inositol research. Vitamin B12 is a cofactor in methionine synthase–dependent methylation. Together, the blend is investigated as metabolic support for hepatic lipid handling rather than as a single-receptor agonist.
Who works with it, and what they are measuring
Nutrition scientists, hepatology-oriented metabolism labs, and compounding-pharmacy quality groups are the primary research audiences. Wellness clinics historically popularized MIC+B12 shots, which is why dosage queries are common, but the evidence base is ingredient-level nutrition science more than peptide pharmacology.
What the research examines
Each tag marks a field where this compound appears in research. Appearing in a literature is not the same as working.
How it appears in the literature
Amounts reported in published research, shown for reference. Not a protocol.
| Research context | Reported amount | Frequency | Route |
|---|---|---|---|
| Common clinic-compounded MIC+B12 injection volumes reported in practice literature | 1 mg | 1–2 times weekly | intramuscular |
| Nutritional research on lipotropic components (not a standardized Lipo-C peptide dose) | 500 mcg – 2 mg | regimen-dependent | intramuscular or oral components |
Handling & storage
Most compounded Lipo-C solutions are stored refrigerated and protected from light per pharmacy label. They are typically already in solution, not lyophilized peptide powder. Follow beyond-use dating on the specific compound.
Notes on combined research
In clinic research discussions Lipo-C appears beside calorie-restricted diet protocols, resistance training, and sometimes GLP-1 receptor agonist programs as supportive micronutrient care. It is also compared with standalone B12 injections when the research question is whether the full MIC matrix adds anything beyond cobalamin repletion.
Lipo-C questions
There is no single peptide-style mcg dose because Lipo-C is a multi-ingredient compounded blend. Many clinic protocols historically used about 1 mL intramuscularly once or twice weekly, but milligram strengths of methionine, inositol, choline, and B12 differ by pharmacy.
Usually none at the point of use. Lipo-C is commonly supplied as a ready-to-inject compounded solution. Bacteriostatic water reconstitution math applies to lyophilized single peptides, not most MIC+B12 vials.
Daily injection is uncommon in published clinic descriptions; weekly or twice-weekly IM schedules are mentioned more often. Oral choline/inositol research uses entirely different day-by-day nutrition doses.
Any honest chart must list each component (methionine mg, inositol mg, choline mg, B12 mcg) per mL for the specific formula. A one-line “peptide dosage chart” is the wrong mental model for this blend.
No. It is a lipotropic nutrient combination, typically MIC+B12. Calling it a peptide is a common search-language mix-up.
Research and clinic write-ups sometimes combine MIC+B12 with diet programs, B-complex vitamins, or separate metabolic agents. Stack rationale should be evidence-based and supervised; this page does not recommend combinations.
Ingredient biochemistry (especially choline) is solid for hepatic fat handling, but robust RCTs showing that injectable MIC+B12 alone produces clinically large fat loss are limited. Treat marketing claims cautiously.
There is no single half-life. B12 can persist in the body for long periods, while methionine, inositol, and choline follow ordinary nutrient kinetics.
Read the research yourself
Each citation was checked against PubMed before it went on this page. If we cannot link it, we do not claim it.